α-2-Microglobulin Elevation at 320 µg/L: Clinical Significance and Management
A β2-microglobulin level of 320 µg/L (0.32 mg/L) is well below the normal upper limit of 2 mg/L and does not indicate renal disease, dialysis-related amyloidosis, or any pathological condition requiring intervention. 1
Understanding the Result
Normal β2-microglobulin serum concentration is less than 2 mg/L (2000 µg/L) in healthy individuals, making your value of 320 µg/L completely within normal range. 1
β2-microglobulin is an 11,800 Da nonglycosylated polypeptide that is normally filtered by the glomerulus and metabolized by the kidney. 1
The protein functions as part of the HLA complex on cell surfaces and is synthesized and shed by many cells, particularly lymphocytes. 2
When β2-Microglobulin Becomes Clinically Significant
Renal Disease Context
Dialysis patients typically have β2-microglobulin levels 15-30 times greater than normal (30-60 mg/L or 30,000-60,000 µg/L), which is approximately 100-200 times higher than your reported value. 1, 3
Elevated serum β2-microglobulin only occurs with impaired renal function when creatinine clearance falls below 70-100 mL/min. 4, 5
Serum β2-microglobulin has a coefficient of -0.87 with creatinine-derived glomerular filtration rate, making it an excellent marker of renal function when truly elevated. 5
Dialysis-Related Amyloidosis
β2-microglobulin amyloidosis manifests clinically 2-10 years after dialysis initiation with carpal tunnel syndrome, spondyloarthropathies, hemarthrosis, and joint pain with immobility. 1, 6
Screening for β2-microglobulin amyloidosis, including measurement of serum levels, is not recommended because no effective therapy exists except kidney transplantation. 1
Clinical Pitfalls to Avoid
Do not confuse α-1-microglobulin (normal range 20-42 mg/L) with β2-microglobulin (normal range <2 mg/L) - these are different proteins with different clinical significance. 4
β2-microglobulin can be transiently elevated during febrile illness without renal disease, but remains well below 10 mg/L in these situations. 5
In patients with actual β2-microglobulin amyloidosis, clinical symptoms may not correlate with serum levels, making the measurement of limited utility even when truly elevated. 3